GSK3B and osteosarcoma: The immunohistochemistry staining results showed that the percentage of GSK3β positive cells in the tumor samples of patients with primary metastatic osteosarcoma was markedly higher than that of patients without metastasis (67.8 ± 5.8% vs. 24.8 ± 3.6%, P<0.001; Figure 1).